Somatostatin receptor (SSTR)-targeted imaging is also an option; however, it is less sensitive in diagnosing insulinomas compared with other pancreatic neuroendocrine neoplasms (11, 12) and does not provide information on its endocrine function, such as insulin secretion. This evidence concerns the gene INS and pancreatic insulinoma.